Armata Pharmaceuticals, Inc.
ARMP
$5.41
-$0.41-7.05%
AMEX
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | 2.51M | 789.00K | 1.09M | 1.16M | 2.17M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 2.51M | 789.00K | 1.09M | 1.16M | 2.17M |
| Cost of Revenue | 7.59M | 6.11M | -1.93M | 5.82M | 6.39M |
| Gross Profit | -5.08M | -5.32M | 3.02M | -4.67M | -4.23M |
| SG&A Expenses | 5.24M | 3.46M | 11.43M | 3.11M | 2.62M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 12.82M | 9.57M | 9.50M | 8.94M | 9.01M |
| Operating Income | -10.31M | -8.79M | -8.41M | -7.78M | -6.84M |
| Income Before Tax | 74.14M | -115.35M | -124.30M | -26.68M | -16.30M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | 74.14M | -115.35M | -124.30M | -26.68M | -16.30M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 74.14M | -115.35M | -124.30M | -26.68M | -16.30M |
| EBIT | -10.31M | -8.79M | -8.41M | -7.78M | -6.84M |
| EBITDA | -9.72M | -8.33M | -7.99M | -7.41M | -6.48M |
| EPS Basic | 2.02 | -3.16 | -3.42 | -0.74 | -0.45 |
| Normalized Basic EPS | -0.29 | -0.24 | -0.23 | -0.21 | -0.18 |
| EPS Diluted | -0.27 | -3.16 | -3.42 | -0.74 | -0.45 |
| Normalized Diluted EPS | -0.17 | -0.24 | -0.23 | -0.21 | -0.18 |
| Average Basic Shares Outstanding | 36.75M | 36.53M | 36.35M | 36.23M | 36.19M |
| Average Diluted Shares Outstanding | 62.04M | 36.53M | 36.35M | 36.23M | 36.19M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |